Key Highlights
- Rigetti secured a preliminary agreement with the Department of Commerce for CHIPS Act funding reaching $100 million across a three-year period.
- Shares of RGTI climbed nearly 20% during Friday’s session, finishing at $26.42 amid a quantum sector-wide rally.
- Federal support will address critical superconducting quantum computing obstacles, including component miniaturization and cooling system design.
- The agreement may grant the government an equity position, potentially affecting current shareholder ownership percentages upon completion.
- Wall Street maintains a Moderate Buy stance on RGTI, with analyst price targets averaging between $29 and $30, suggesting limited near-term growth potential.
Rigetti Computing (RGTI) shares climbed nearly 20% during Friday’s trading after the quantum computing specialist announced a preliminary funding agreement with the U.S. Department of Commerce worth up to $100 million under the CHIPS Act. The stock settled at $26.42 for the session.
This allocation represents a portion of Washington’s comprehensive $2.013 billion investment initiative authorized by the CHIPS and Science Act, distributed among nine technology companies. The majorityâseven recipientsâare quantum computing specialists, with D-Wave, PsiQuantum, Quantinuum, and Infleqtion among the beneficiaries. Traditional semiconductor players IBM and GlobalFoundries also received federal backing.
Rigetti’s allocationâpotentially reaching $100 million distributed over 36 monthsâwill specifically support advancement and commercialization of next-generation superconducting quantum technologies. Priority areas include compact readout electronics development and enhanced cryogenic cooling system design.
CEO Subodh Kulkarni described the commitment as validation from federal authorities. “This capital infusion will enable us to address critical scaling challenges more aggressively and advance toward commercially viable quantum computing solutions,” he explained.
A significant consideration: the arrangement may include federal equity participation proportional to funding levels. This differs from traditional research grantsâeffectively establishing government ownership interest in Rigetti’s technological advancement. Current shareholders should recognize potential ownership dilution if the preliminary agreement reaches final terms.
Rigetti’s Technical Differentiation
Rigetti’s fundamental technology relies on superconducting qubit systemsâsimilar foundational physics employed by IBM and Alphabet, but with architectural distinctions. The company implements a modular chiplet methodology, assembling smaller quantum processors into larger computational frameworks.
The company’s 108-qubit Cepheus system exemplifies this strategy, constructed from twelve separate 9-qubit chiplets. This modular approach aims to simplify scaling by circumventing manufacturing complications inherent in monolithic large-scale chip production. Quantum gate operations execute within 50 to 70 nanoseconds, demonstrating competitive performance against alternative quantum methodologies.
This strategy differentiates Rigetti from IonQ’s trapped-ion methodology and IBM‘s substantially larger resource base. Rigetti’s market positioning emphasizes vertical integration: complete technological control, rapid superconducting architectures, and deployment flexibility across cloud platforms and dedicated installationsâparticularly serving government research facilities requiring classified computing environments incompatible with public cloud infrastructure.
Wall Street Perspective and Financial Performance
Analyst sentiment remains guardedly positive. Among 13 firms providing coverage, eight recommend buying, four advise holding, and one suggests selling. Consensus 12-month valuation targets cluster around $29â$30, indicating approximately 13% appreciation potential from Friday’s closing price.
Rigetti’s latest quarterly disclosure exceeded market expectations. The firm recorded earnings per share of -$0.04, outperforming the -$0.05 consensus forecast. Quarterly revenue reached $4.4 million, representing 198.9% year-over-year expansion and surpassing the $4.09 million analyst estimate.
The stock benefited additionally from sector-wide momentum following the federal funding announcement. Competing firms IonQ and D-Wave advanced 8% and 14% respectively during the same trading session. RGTI has appreciated approximately 48% on a week-to-week comparison.
Benchmark sustained its buy recommendation while reducing its valuation target from $35 to $25. Rosenblatt maintains a $40 objective. The stock’s 52-week trading range spans $10.30 to $58.15, with the 50-day moving average positioned at $16.82.





